Xenon and Neurocrine Biosciences announced a partnership on August 12, 2025, allowing collaboration and milestone payments regarding Azetukalner, which is Xenon's lead pipeline candidate.
2 reports, 2 independent
Updated Tue 00:00
No new developments lately
- Reports
- 2
- Developments
- 2
- Repetition
- 0%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Xenon and Neurocrine Biosciences announced a partnership on August 12, 2025, allowing collaboration and milestone payments regarding Azetukalner, which is Xenon's lead pipeline candidate.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.Keep exploring
The entities involved
-
Xenon
nightclub in New York City
-
Neurocrine Biosciences
American biopharmaceutical company
Nothing else this week.